CAMBRIDGE, MA--(Marketwire - December 18, 2007) - Phylonix Pharmaceuticals today announced that it recently received a broadly issued European patent: EP 1 135 531 B1 "Methods for Introducing Heterologous Cells into Fish." The patent, which has issued in key European countries, encompasses 68 claims, including transplanting stem cells, cancer cells and pathogens. In addition, neurons, chondrocytes, renal and hepatic cells can be transplanted in zebrafish and effects of growth factors or cytotoxic agents can be assessed. Claims also cover recovering cells for potential tissue engineering or transplantation applications. Many of these claims have issued previously in the United States and other countries.
